Tan Sri Dr M. Mahadevan, the towering figure who shaped Malaysia's psychiatric landscape over six decades, passed away yesterday evening at his Ampang residence after suffering from cardiovascular and respiratory ailments. The 96-year-old clinician, widely celebrated as the architect of the country's modern mental health system, breathed his last surrounded by his family at approximately 7.45 pm, leaving behind an unparalleled legacy in a field that was nascent when he began his career in the late 1950s.

According to his carer Thenagaran, Dr Mahadevan had been under medical supervision at a private facility in Ampang for the preceding month, where he was being treated for heart failure and a lung infection. His condition had deteriorated steadily, prompting his decision to return home for his final days rather than remain hospitalised. The decision reflected both his pragmatic nature and perhaps a conscious choice to spend his remaining time in familiar surroundings with loved ones rather than in an institutional setting.

Born on September 9, 1929, Dr Mahadevan's educational journey took him across continents. He received his foundational schooling at St John's Institution in Kuala Lumpur before proceeding to complete his medical qualification in Bangalore, India, in 1961. His postgraduate training extended to University College Dublin in Ireland, exposing him to diverse psychiatric methodologies and international best practices during a formative period in global mental health development.

The turning point in his career came in 1967 when Tunku Abdul Rahman Putra Al-Haj, Malaysia's first Prime Minister, personally requested that Dr Mahadevan return home to establish a structured mental healthcare infrastructure. At that time, Malaysia's psychiatric services were rudimentary and fragmented, lacking the institutional framework and professional standards characteristic of developed nations. Dr Mahadevan's appointment as the inaugural director of what would become Hospital Bahagia Ulu Kinta—originally known as the Central Mental Hospital—marked the beginning of systematic psychiatric care provision in the country.

Dr Mahadevan's most enduring institutional contribution was his founding and leadership of the Malaysian Psychiatric Association, through which he professionalised the discipline and elevated standards of practice across the nation. During the 1980s, he served as the government's chief psychiatrist, a position that gave him considerable influence over policy formulation and resource allocation for mental health programmes. This period witnessed significant expansion of psychiatric facilities and the integration of mental health services into the broader healthcare ecosystem, fundamentally altering how Malaysians accessed treatment for psychological and behavioural conditions.

His scholarly reputation extended well beyond Malaysia's borders. Dr Mahadevan's pioneering work in hypnotherapy and its clinical applications garnered international acclaim, culminating in Harvard University establishing a travel scholarship programme bearing his name. This recognition underscored his status as a thought leader in a specialised domain, contributing to medical literature and clinical protocols that influenced psychiatric practice across Asia and beyond. He became the first Malaysian appointed to the presidency of the Asian Branch of the International College of Psychosomatic Medicine, an honour reflecting the respect his peers accorded to his clinical expertise and leadership acumen.

The significance of Dr Mahadevan's contributions becomes clearer when contextualised within Malaysia's broader healthcare development. When he commenced his career, psychiatric conditions were often stigmatised, poorly understood, and addressed through traditional rather than clinical frameworks. Through systematic advocacy, institution-building, and evidence-based practice promotion, he fundamentally reoriented public and professional attitudes towards mental illness. The transformation of Malaysia's psychiatric services from a marginal concern to an integral healthcare component owes substantially to his visionary leadership and sustained commitment.

For Malaysian healthcare professionals and policymakers, Dr Mahadevan's career exemplifies how individual expertise and institutional positioning can catalyse systemic change. His approach—combining international exposure with local problem-solving, grounding advocacy in scientific evidence, and building professional communities—remains instructive for contemporary health reform efforts. The mental health challenges facing modern Malaysia, including rising depression and anxiety prevalence, insufficient psychiatric workforce capacity, and stigma persistence, represent ongoing struggles that build upon the foundational work he initiated decades ago.

The passing of Dr Mahadevan occurs at a moment when mental health receives unprecedented policy attention across Southeast Asia, driven by pandemic-related psychological impacts and demographic shifts. His life trajectory demonstrates how psychiatric development in emerging economies requires sustained individual commitment, institutional innovation, and willingness to challenge prevailing cultural attitudes. Current and future generations of Malaysian psychiatrists inherit not merely clinical knowledge but also a professional tradition emphasising rigorous standards and public responsibility that Dr Mahadevan embodied throughout his career.

Family members and colleagues will have the opportunity to pay respects at his Ukay Heights residence on June 16 and 17, with viewing hours from 10 am to 1 pm and 3 pm to 6 pm both days. The funeral service will proceed on June 18 at 9.30 am at the same location, followed by his body being transported to the Sentul Hindu Crematorium at midday. His passing marks the conclusion of an era in Malaysian psychiatry, though his institutional contributions, professional standards, and pioneering spirit will continue shaping the discipline for generations ahead.